Literature DB >> 24552619

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

Kelly A Allott1, Miriam R Schäfer2, Andrew Thompson3, Barnaby Nelson4, Sarah Bendall4, Cali F Bartholomeusz5, Hok Pan Yuen4, Patrick D McGorry4, Monika Schlögelhofer6, Andreas Bechdolf7, G Paul Amminger2.   

Abstract

AIMS: Recent research has shown emotion recognition to be impaired in individuals at ultra-high risk (UHR) for developing a psychotic disorder compared to healthy controls. This longitudinal study aimed to examine whether disturbed emotion recognition measured in UHR participants at baseline predicts transition to a psychotic disorder within 12months.
METHODS: Thirty-seven UHR participants aged 13-22years participated in the study. At baseline participants completed face and prosody emotion recognition tasks, as well as measures of psychopathology, functioning, and IQ. Transition to a psychotic disorder over 12months was the primary outcome. A series of Cox regressions was performed with emotion recognition as the predictor variable, while controlling for covariates, with time to transition to a psychotic disorder as the dependent variable.
RESULTS: Eleven (29.7%) of the 37 participants transitioned to a psychotic disorder over the 12-month follow-up period. Total face or prosody emotion recognition accuracy was not predictive of transition to a psychotic disorder. However, examination of recognition of specific emotions, while controlling for positive, negative and global symptoms and functioning, revealed that accuracy in identifying neutral (p=.037) and fearful (p=.015) emotion predicted transition to a psychotic disorder. Specifically, lower accuracy in identifying neutral emotion and higher accuracy in identifying fearful emotion were predictive of transition to a psychotic disorder within 12months. Examination of the separate modalities revealed that this finding held for face but not for prosody emotion recognition.
CONCLUSION: These findings suggest that emotion recognition abilities may be prognostic for the development of psychotic disorders, but further studies are needed.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affect recognition; Conversion; Early psychosis; Fear; Neutral emotion; Trait marker

Mesh:

Year:  2014        PMID: 24552619     DOI: 10.1016/j.schres.2014.01.037

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  22 in total

1.  Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.

Authors:  C M Corcoran; J G Keilp; J Kayser; C Klim; P D Butler; G E Bruder; R C Gur; D C Javitt
Journal:  Psychol Med       Date:  2015-06-04       Impact factor: 7.723

2.  Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.

Authors:  Danijela Piskulic; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Jean Addington
Journal:  Schizophr Res       Date:  2016-01-16       Impact factor: 4.939

3.  Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion.

Authors:  Luca Kleineidam; Ingo Frommann; Stephan Ruhrmann; Joachim Klosterkötter; Anke Brockhaus-Dumke; Wolfgang Wölwer; Wolfgang Gaebel; Wolfgang Maier; Michael Wagner; Ulrich Ettinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-11       Impact factor: 5.270

4.  Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function.

Authors:  Raquel E Gur; Mary March; Monica E Calkins; Lauren Weittenhiller; Daniel H Wolf; Bruce I Turetsky; Ruben C Gur
Journal:  Schizophr Res       Date:  2015-06-17       Impact factor: 4.939

5.  Neural correlates of aberrant emotional salience predict psychotic symptoms and global functioning in high-risk and first-episode psychosis.

Authors:  Gemma Modinos; Huai-Hsuan Tseng; Irina Falkenberg; Carly Samson; Philip McGuire; Paul Allen
Journal:  Soc Cogn Affect Neurosci       Date:  2015-03-25       Impact factor: 3.436

6.  Neuropsychological deficits in participants at clinical high risk for psychosis recruited from the community: relationships to functioning and clinical symptoms.

Authors:  Kate Haining; Claire Matrunola; Lucy Mitchell; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Peter J Uhlhaas
Journal:  Psychol Med       Date:  2019-03-13       Impact factor: 7.723

7.  Neurodevelopmental Genomic Strategies in the Study of the Psychosis Spectrum.

Authors:  Raquel E Gur
Journal:  Nebr Symp Motiv       Date:  2016

Review 8.  A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis.

Authors:  Justin Davis; Harris Eyre; Felice N Jacka; Seetal Dodd; Olivia Dean; Sarah McEwen; Monojit Debnath; John McGrath; Michael Maes; Paul Amminger; Patrick D McGorry; Christos Pantelis; Michael Berk
Journal:  Neurosci Biobehav Rev       Date:  2016-04-09       Impact factor: 8.989

9.  An Event-Related Potential Investigation of Early Visual Processing Deficits During Face Perception in Youth at Clinical High Risk for Psychosis.

Authors:  K Juston Osborne; Brian Kraus; Tim Curran; Holly Earls; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

10.  Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of Psychosis.

Authors:  Stefania Tognin; Ana Catalan; Gemma Modinos; Matthew J Kempton; Amaia Bilbao; Barnaby Nelson; Christos Pantelis; Anita Riecher-Rössler; Rodrigo Bressan; Neus Barrantes-Vidal; Marie-Odile Krebs; Merete Nordentoft; Stephan Ruhrmann; Gabriele Sachs; Bart P F Rutten; Jim van Os; Lieuwe de Haan; Mark van der Gaag; Philip McGuire; Lucia R Valmaggia
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.